Cargando…
Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
Autores principales: | Parisi, Eva, Marqués, Marta, Pont, Mariona, Sorolla, Maria Alba, Sorolla, Anabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272586/ https://www.ncbi.nlm.nih.gov/pubmed/35832561 http://dx.doi.org/10.3389/fonc.2022.912542 |
Ejemplares similares
-
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
por: Pont, Mariona, et al.
Publicado: (2023) -
MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions
por: Marqués, Marta, et al.
Publicado: (2023) -
Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
por: Marqués, Marta, et al.
Publicado: (2022) -
An N-ethyl-N-Nitrosourea Mutagenesis Screen in Mice Reveals a Mutation in Nuclear Respiratory Factor 1 (Nrf1) Altering the DNA Methylation State and Correct Embryonic Development
por: Sorolla, Maria Alba, et al.
Publicado: (2021) -
Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
por: Sorolla, Maria Alba, et al.
Publicado: (2021)